Lynx Prototoxins: Roles of Endogenous Mammalian Neurotoxin-Like Proteins in Modulating Nicotinic Acetylcholine Receptor Function to Influence Complex Biological Processes
Autor: | Katie M. Hoffman, Julie M. Miwa, Kristin R. Anderson |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Review Biology 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine cholinergic modulation LYNX1 medicine Neurotoxin Pharmacology (medical) Receptor Neurotransmitter Pharmacology learning lcsh:RM1-950 toxins Nicotinic acetylcholine receptor 030104 developmental biology Nicotinic agonist lcsh:Therapeutics. Pharmacology chemistry 030220 oncology & carcinogenesis plasticity Cholinergic Neuroscience Acetylcholine medicine.drug nicotine |
Zdroj: | Frontiers in Pharmacology, Vol 10 (2019) Frontiers in Pharmacology |
ISSN: | 1663-9812 |
DOI: | 10.3389/fphar.2019.00343 |
Popis: | The cholinergic system modulates many biological functions, due to the widespread distribution of cholinergic neuronal terminals, and the diffuse release of its neurotransmitter, acetylcholine. Several layers of regulation help to refine and control the scope of this excitatory neurotransmitter system. One such regulatory mechanism is imparted through endogenous toxin-like proteins, prototoxins, which largely control the function of nicotinic receptors of the cholinergic system. Prototoxins and neurotoxins share the distinct three finger toxin fold, highly effective as a receptor binding protein, and the former are expressed in the mammalian brain, immune system, epithelium, etc. Prototoxins and elapid snake neurotoxins appear to be related through gene duplication and divergence from a common ancestral gene. Protein modulators can provide a graded response of the cholinergic system, and within the brain, stabilize neural circuitry through direct interaction with nicotinic receptors. Understanding the roles of each prototoxin (e.g., lynx1, lynx2/lypd1, PSCA, SLURP1, SLURP2, Lypd6, lypd6b, lypdg6e, PATE-M, PATE-B, etc.), their binding specificity and unique expression profile, has the potential to uncover many fascinating cholinergic-dependent mechanisms in the brain. Each family member can provide a spatially restricted level of control over nAChR function based on its expression in the brain. Due to the difficulty in the pharmacological targeting of nicotinic receptors in the brain as a result of widespread expression patterns and similarities in receptor sequences, unique interfaces between prototoxin and nicotinic receptor could provide more specific targeting than nicotinic receptors alone. As such, this family is intriguing from a long-term therapeutic perspective. |
Databáze: | OpenAIRE |
Externí odkaz: |